Cyanocobalamin/folic acid/pyridoxine/strontium gluconate Drug Interactions
Currently displaying a list of 109 drugs known to interact with cyanocobalamin / folic acid / pyridoxine / strontium gluconate.
- 3 major drug interactions
- 77 moderate drug interactions
- 29 minor drug interactions
Medications known to interact with cyanocobalamin/folic acid/pyridoxine/strontium gluconate
Note: Showing generic names only.
A
- alendronate
- altretamine
- aluminum carbonate
- aluminum hydroxide
- aminosalicylic acid
- amobarbital
- arsenic trioxide
B
C
- calcium acetate
- calcium carbonate
- calcium citrate
- calcium glubionate
- calcium gluconate
- calcium lactate
- calcium phosphate, tribasic
- calcium saccharate
- capecitabine
- carbamazepine
- chloramphenicol
- cholestyramine
- cimetidine
- cinoxacin
- ciprofloxacin
- colestipol
D
- deferiprone
- delafloxacin
- demeclocycline
- dexlansoprazole
- dihydroxyaluminum sodium carbonate
- divalproex sodium
- doxycycline
E
F
G
I
L
M
- magaldrate
- magnesium carbonate
- magnesium hydroxide
- magnesium oxide
- mephenytoin
- mephobarbital
- methohexital
- methotrexate
- methsuximide
- minocycline
- moxifloxacin
- multivitamin with minerals
- multivitamin, prenatal
N
O
P
- pafolacianine
- pancreatin
- pancrelipase
- pantoprazole
- penicillamine
- pentobarbital
- phenobarbital
- phensuximide
- phenytoin
- potassium chloride
- primidone
- pyrimethamine
R
S
- sarecycline
- secobarbital
- sodium bicarbonate
- sodium citrate
- sparfloxacin
- sulfadiazine
- sulfadoxine
- sulfamethizole
- sulfamethoxazole
- sulfasalazine
- sulfisoxazole
T
V
Cyanocobalamin/folic acid/pyridoxine/strontium gluconate alcohol/food interactions
There are 2 alcohol/food interactions with cyanocobalamin / folic acid / pyridoxine / strontium gluconate.
Cyanocobalamin/folic acid/pyridoxine/strontium gluconate disease interactions
There are 6 disease interactions with cyanocobalamin / folic acid / pyridoxine / strontium gluconate which include:
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.